|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Net product sales ($48,860 and $47,514 sold to related parties for the years ended December 31, 2024 and 2023) | |||||
| Cost of products sold ($30,088 and $27,288 purchased from related parties for the years ended December 31, 2024 and 2023) | |||||
| Gross profit | |||||
| Net gain on other sales | |||||
| Operating expenses: | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other income, net | |||||
| Interest expense | |||||
| Interest Expenses | |||||
| Financial (expense)/income, net | |||||
| Income before income tax expenses and equity in earnings of affiliated companies | |||||
| Less: Income taxes | |||||
| Add: Equity in loss of affiliated companies | |||||
| Net income | |||||
| Net income attributable to non-controlling interest | |||||
| Accretion to redemption value of redeemable non-controlling interests | |||||
| Net income attributable to parent company's common shareholders | |||||
| Net income attributable to parent company's common shareholders per share - | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding - | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...